{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81836",
      "recalling_firm": "Akorn Inc",
      "address_1": "1925 W Field Ct Ste 300",
      "address_2": "N/A",
      "postal_code": "60045-4862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide USA and Puerto Rico",
      "recall_number": "D-0483-2019",
      "product_description": "COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10",
      "product_quantity": "30,794 bottles",
      "reason_for_recall": "Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.",
      "recall_initiation_date": "20181220",
      "center_classification_date": "20190208",
      "termination_date": "20201106",
      "report_date": "20190220",
      "code_info": "Lots: 426007 and 426008, exp 4/2020"
    }
  ]
}